FDA Approved: ORFADIN — Supplemental Application (Swedish Orphan Biovitrum AB (publ))

View source ↗

Summary

The FDA approved a supplemental application for Orfadin (nitisinone) submitted by Swedish Orphan Biovitrum AB (publ), updating the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Tyrosinemia Type

Drugs mentioned

• Orfadin (nitisinone)

Snippet

SUPPL AP for ORFADIN (NITISINONE)